Literature DB >> 2222091

Treatment of adult chickenpox with oral acyclovir.

H M Feder1.   

Abstract

Thirty-one late adolescents and adults with varicella were studied. Patients identified within 72 hours of varicella exanthem were offered open treatment with acyclovir (4 g/d), and those patients identified after 72 hours of exanthem were followed up but not treated. Twenty-two patients were treated with acyclovir. Nine patients were not treated. No severe complications occurred in any of the 31 patients. Minor complications, including prolonged fever, localized secondary infections, persistent cough, and prolonged fatigue were more frequent in the untreated group. If the acyclovir therapy was begun within the first 24 hours of varicella exanthem, then the rash and clinical illness were dramatically lessened. Treatment with oral acyclovir should be considered for varicella in adults who are identified within the first 24 hours of exanthem.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2222091

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

1.  Managing childhood chickenpox: cost implications.

Authors:  P A Brunell
Journal:  Pharmacoeconomics       Date:  1993-02       Impact factor: 4.981

2.  Acyclovir for varicella in immunocompetent patients.

Authors:  J L Kimpen; H S Heymans
Journal:  Clin Investig       Date:  1993-06

3.  Cost effectiveness of early treatment with oral aciclovir in adult chickenpox.

Authors:  K J Smith; M S Roberts
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

4.  Immunoelectron microscopy for rapid diagnosis of varicella-zoster virus in a complicated case of human T-cell lymphotropic virus type 1 infection.

Authors:  E Folkers; J Vreeswijk; F Wagenaar; J G Kapsenberg; H J Hulsebosch; A P Oranje
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

Review 5.  Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  A J Wagstaff; D Faulds; K L Goa
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

Review 6.  Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment.

Authors:  R Snoeck; G Andrei; E De Clercq
Journal:  Drugs       Date:  1999-02       Impact factor: 11.431

Review 7.  Acyclovir for treating varicella in otherwise healthy children and adolescents: a systematic review of randomised controlled trials.

Authors:  Terry P Klassen; Elaine M Belseck; Natasha Wiebe; Lisa Hartling
Journal:  BMC Pediatr       Date:  2002-09-30       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.